5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health Enters into Exclusive Development and Intellectual Property Agreement for CannaMint Strips and Files Additional Trademarks for CannaStrips and CanRelief
24 mai 2018 08h30 HE | Callitas Health Inc.
CINCINNATI, OH, May 24, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health Signs Dr. Gregory Smith MD, MPH, as the Company's Chief Medical Cannabis Advisor
21 mai 2018 10h55 HE | Callitas Health Inc.
CINCINNATI, OH, May 21, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...
5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health Interim President & CEO Will Present at the 2018 Proactive's CEO Investors Forum
09 mai 2018 08h30 HE | Callitas Health Inc.
CINCINNATI, OH & NEW YORK, NY, May 09, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage...
5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health, Inc. Releases Annual Update Letter to Shareholders
19 avr. 2018 09h46 HE | Callitas Health Inc.
CINCINNATI, OH, April 19, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2) today announced that Interim President and Chief Executive Officer, James Thompson, has...
5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health, Inc. Signs Multiple Letters of Intent for Distribution of CannaMint Strips in California
16 avr. 2018 08h00 HE | Callitas Health Inc.
CINCINNATI, OH & LOS ANGELES, CA , April 16, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the "Company" or “Callitas”) an integrated clinical-stage...
5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health Announces Response from US FDA on Orphan Drug Designation and Rare Pediatric Disease Designation Requests
15 mars 2018 08h30 HE | Callitas Health Inc.
CINCINNATI, OH, March 15, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
5a9d48eb3ccfe10004c054ad_1.jpg
UPDATE: Callitas Health Announces Selection of TraDigitalIR as Investor and Public Relations Advisor
15 mars 2018 06h00 HE | Callitas Health Inc.
CINCINNATI and NEW YORK, March 15, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health Announces Selection of TraDigitalIR as Investor and Public Relations Advisor
13 mars 2018 12h10 HE | Callitas Health Inc.
CINCINNATI and NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health, Inc Receives Notice of Allowance from USPTO for Patent Application for Treatment for Male Infertility and Sub-Fertility
08 mars 2018 18h17 HE | Callitas Health Inc.
CINCINNATI, OH , March 08, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...
5a9d48eb3ccfe10004c054ad_1.jpg
Callitas Health Inc., Announces New Partnership with NFI Consumer Healthcare's e.p.t. Pregnancy Test Line
05 mars 2018 11h27 HE | Callitas Health Inc.
CINCINNATI, OH, March 05, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing innovative...